Narrow search
Showing 1 - 10 of 78
Cover Image
Valuing EQ-5D-5L health states "in context" using a discrete choice experiment
Cole, Amanda; Shah, Koonal; Feng, Yan; Devlin, Nancy - In: The European journal of health economics : HEPAC ; … 19 (2018) 4, pp. 595-605
Persistent link: https://www.econbiz.de/10011947134
Cover Image
Valuation of preference-based measures : can existing preference data be used to select a smaller sample of health states?
Kharroubi, Samer A.; Rowen, Donna - In: The European journal of health economics : HEPAC ; … 20 (2019) 2, pp. 245-255
Persistent link: https://www.econbiz.de/10012004855
Cover Image
Is anchoring at "dead" a theoretical requirement for health state valuation?
Sampson, Chris; Parkin, David; Devlin, Nancy - In: Health economics 33 (2024) 9, pp. 1929-1935
Persistent link: https://www.econbiz.de/10015095019
Cover Image
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study
Hansen, Tonya Moen; Stavem, Knut; Rand, Kim - In: The European journal of health economics 24 (2023) 6, pp. 877-884
Persistent link: https://www.econbiz.de/10014328133
Cover Image
Health state utilities for skeletal-related events secondary to bone metastases
Matza, Louis S.; Chung, Karen; Van Brunt, Kate; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 1, pp. 7-18
Persistent link: https://www.econbiz.de/10010235900
Cover Image
Health state utilities associated with attributes of treatments for hepatitis C
Matza, Louis; Sapra, Sandhya J.; Dillon, John F.; … - In: The European journal of health economics : HEPAC ; … 16 (2015) 9, pp. 1005-1018
Persistent link: https://www.econbiz.de/10011483995
Cover Image
The Role of decision-analytic modelling in German health technology assessments
Kuhlmann, Alexander; Treskova, Marina; Braun, Sebastian; … - In: Health economics review 5 (2015) 7, pp. 1-7
Background: Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical...
Persistent link: https://www.econbiz.de/10010530072
Cover Image
How relevant are social costs in economic evaluations? : the case of Alzheimer's disease
Peña-Longobardo, L. M.; Rodríguez-Sánchez, B.; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 8, pp. 1207-1236
Persistent link: https://www.econbiz.de/10012221328
Cover Image
Does the inclusion of societal costs change the economic evaluations recommendations? : a systematic review for multiple sclerosis disease
Rodríguez-Sánchez, Beatriz; Daugbjerg, S.; … - In: The European journal of health economics 24 (2023) 2, pp. 247-277
Persistent link: https://www.econbiz.de/10014327973
Cover Image
Values for health states with different life durations
Scalone, Luciana; Stalmeier, Peep F.M.; Milani, Silvano; … - In: The European journal of health economics : HEPAC ; … 16 (2015) 9, pp. 917-925
Persistent link: https://www.econbiz.de/10011483828